trastuzumab,tucatinib
Seagen,Roche
['lba27', 'tucatinib', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'mountaineer']
look out for additional data from #mountaineer trial being presented at #esmo2022: a phase ii study of #tucatinib and #trastuzumab for #her2-positive #mcrc! 12/09/2022, 14:50 mini oral session: gi, lower digestive, lba27 #meded 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB